Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation

Yoram Zilberman, Gadi Turgeman, Gadi Pelled, Nong Xu, Ioannis K. Moutsatsos, Gonzalo Hortelano, Dan Gazit

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We have previously shown that genetically engineered adult mesenchymal stem cells (AMSCs) expressing recombinant human bone morphogenetic protein -2 (rhBMP-2), under tet-regulation, can induce bone formation and regeneration. We showed that these cells induce bone formation via paracrine and autocrine effect of the secreted rhBMP-2 protein. To distinguish between these two effects, and to develop a platform for continuous delivery of rhBMP-2 by engineered cells protected from the immune system, we have used hydrogel polymer (alginate) in order to encapsulate the AMSCs. Mixing of the cells with potassium alginate, followed by sedimentation in Ca2+ solution, results in polymerization of the alginate around the cells, forming microcapsules composed of a membrane allowing diffusion of small molecule and proteins. Encapsulated engineered AMSCs were able to survive inside the capsules in vitro and in vivo and secrete rhBMP-2 under tet-regulation. Transplantation of capsules both subcutaneously and into bone defect elicited physiological response manifested in osteogenic tissue composed of bone trabeculae and cartilage. Inside the capsules, engineered AMSCs differentiated to chondrocytes (autocrine effect), but not to osteoblasts. Newly formed bone has developed around the polymeric external layer without any observed intermediate layer of tissue. There was no evidence of immune response in the transplants area. We therefore conclude that engineered AMSCs can be efficiently encapsulated within polymeric alginate microcapsules, maintain viability, differentiate by autocrine effect, secrete rhBMP-2 under exogenous regulation, and induce bone formation by paracrine effect, with no adverse or immune response to the transplanted capsules.

Original languageEnglish
Pages (from-to)863-870
Number of pages8
JournalPolymers for Advanced Technologies
Volume13
Issue number10-12
Publication statusPublished - Oct 2002
Externally publishedYes

Fingerprint

Stem cells
Capsules
Polymers
Bone
Tissue
Proteins
Alginate
Transplants
Immune system
Hydrogel
Osteoblasts
Cartilage
Sedimentation
recombinant human bone morphogenetic protein-2
Polymerization
Membranes
Defects
Molecules
alginic acid
Hydrogels

Keywords

  • Alginate
  • Bone formation
  • Fracture healing
  • Gene theraphy
  • Mesenchymal stem cell
  • Micro-encapsulation
  • RhBMP-2

ASJC Scopus subject areas

  • Polymers and Plastics

Cite this

Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation. / Zilberman, Yoram; Turgeman, Gadi; Pelled, Gadi; Xu, Nong; Moutsatsos, Ioannis K.; Hortelano, Gonzalo; Gazit, Dan.

In: Polymers for Advanced Technologies, Vol. 13, No. 10-12, 10.2002, p. 863-870.

Research output: Contribution to journalArticle

Zilberman, Yoram ; Turgeman, Gadi ; Pelled, Gadi ; Xu, Nong ; Moutsatsos, Ioannis K. ; Hortelano, Gonzalo ; Gazit, Dan. / Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation. In: Polymers for Advanced Technologies. 2002 ; Vol. 13, No. 10-12. pp. 863-870.
@article{8e81797e85564beb8d69e9fa2e290ab7,
title = "Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation",
abstract = "We have previously shown that genetically engineered adult mesenchymal stem cells (AMSCs) expressing recombinant human bone morphogenetic protein -2 (rhBMP-2), under tet-regulation, can induce bone formation and regeneration. We showed that these cells induce bone formation via paracrine and autocrine effect of the secreted rhBMP-2 protein. To distinguish between these two effects, and to develop a platform for continuous delivery of rhBMP-2 by engineered cells protected from the immune system, we have used hydrogel polymer (alginate) in order to encapsulate the AMSCs. Mixing of the cells with potassium alginate, followed by sedimentation in Ca2+ solution, results in polymerization of the alginate around the cells, forming microcapsules composed of a membrane allowing diffusion of small molecule and proteins. Encapsulated engineered AMSCs were able to survive inside the capsules in vitro and in vivo and secrete rhBMP-2 under tet-regulation. Transplantation of capsules both subcutaneously and into bone defect elicited physiological response manifested in osteogenic tissue composed of bone trabeculae and cartilage. Inside the capsules, engineered AMSCs differentiated to chondrocytes (autocrine effect), but not to osteoblasts. Newly formed bone has developed around the polymeric external layer without any observed intermediate layer of tissue. There was no evidence of immune response in the transplants area. We therefore conclude that engineered AMSCs can be efficiently encapsulated within polymeric alginate microcapsules, maintain viability, differentiate by autocrine effect, secrete rhBMP-2 under exogenous regulation, and induce bone formation by paracrine effect, with no adverse or immune response to the transplanted capsules.",
keywords = "Alginate, Bone formation, Fracture healing, Gene theraphy, Mesenchymal stem cell, Micro-encapsulation, RhBMP-2",
author = "Yoram Zilberman and Gadi Turgeman and Gadi Pelled and Nong Xu and Moutsatsos, {Ioannis K.} and Gonzalo Hortelano and Dan Gazit",
year = "2002",
month = "10",
language = "English",
volume = "13",
pages = "863--870",
journal = "Polymers for Advanced Technologies",
issn = "1042-7147",
publisher = "John Wiley and Sons Ltd",
number = "10-12",

}

TY - JOUR

T1 - Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation

AU - Zilberman, Yoram

AU - Turgeman, Gadi

AU - Pelled, Gadi

AU - Xu, Nong

AU - Moutsatsos, Ioannis K.

AU - Hortelano, Gonzalo

AU - Gazit, Dan

PY - 2002/10

Y1 - 2002/10

N2 - We have previously shown that genetically engineered adult mesenchymal stem cells (AMSCs) expressing recombinant human bone morphogenetic protein -2 (rhBMP-2), under tet-regulation, can induce bone formation and regeneration. We showed that these cells induce bone formation via paracrine and autocrine effect of the secreted rhBMP-2 protein. To distinguish between these two effects, and to develop a platform for continuous delivery of rhBMP-2 by engineered cells protected from the immune system, we have used hydrogel polymer (alginate) in order to encapsulate the AMSCs. Mixing of the cells with potassium alginate, followed by sedimentation in Ca2+ solution, results in polymerization of the alginate around the cells, forming microcapsules composed of a membrane allowing diffusion of small molecule and proteins. Encapsulated engineered AMSCs were able to survive inside the capsules in vitro and in vivo and secrete rhBMP-2 under tet-regulation. Transplantation of capsules both subcutaneously and into bone defect elicited physiological response manifested in osteogenic tissue composed of bone trabeculae and cartilage. Inside the capsules, engineered AMSCs differentiated to chondrocytes (autocrine effect), but not to osteoblasts. Newly formed bone has developed around the polymeric external layer without any observed intermediate layer of tissue. There was no evidence of immune response in the transplants area. We therefore conclude that engineered AMSCs can be efficiently encapsulated within polymeric alginate microcapsules, maintain viability, differentiate by autocrine effect, secrete rhBMP-2 under exogenous regulation, and induce bone formation by paracrine effect, with no adverse or immune response to the transplanted capsules.

AB - We have previously shown that genetically engineered adult mesenchymal stem cells (AMSCs) expressing recombinant human bone morphogenetic protein -2 (rhBMP-2), under tet-regulation, can induce bone formation and regeneration. We showed that these cells induce bone formation via paracrine and autocrine effect of the secreted rhBMP-2 protein. To distinguish between these two effects, and to develop a platform for continuous delivery of rhBMP-2 by engineered cells protected from the immune system, we have used hydrogel polymer (alginate) in order to encapsulate the AMSCs. Mixing of the cells with potassium alginate, followed by sedimentation in Ca2+ solution, results in polymerization of the alginate around the cells, forming microcapsules composed of a membrane allowing diffusion of small molecule and proteins. Encapsulated engineered AMSCs were able to survive inside the capsules in vitro and in vivo and secrete rhBMP-2 under tet-regulation. Transplantation of capsules both subcutaneously and into bone defect elicited physiological response manifested in osteogenic tissue composed of bone trabeculae and cartilage. Inside the capsules, engineered AMSCs differentiated to chondrocytes (autocrine effect), but not to osteoblasts. Newly formed bone has developed around the polymeric external layer without any observed intermediate layer of tissue. There was no evidence of immune response in the transplants area. We therefore conclude that engineered AMSCs can be efficiently encapsulated within polymeric alginate microcapsules, maintain viability, differentiate by autocrine effect, secrete rhBMP-2 under exogenous regulation, and induce bone formation by paracrine effect, with no adverse or immune response to the transplanted capsules.

KW - Alginate

KW - Bone formation

KW - Fracture healing

KW - Gene theraphy

KW - Mesenchymal stem cell

KW - Micro-encapsulation

KW - RhBMP-2

UR - http://www.scopus.com/inward/record.url?scp=0036825851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036825851&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 863

EP - 870

JO - Polymers for Advanced Technologies

JF - Polymers for Advanced Technologies

SN - 1042-7147

IS - 10-12

ER -